Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
The Journal of Physiology|July 18, 2018
ERG3 potassium channel-mediated suppression of neuronal intrinsic excitability and prevention of seizure generation in miceKuo Xiao, Zhiming Sun, Xueqin Jin, et al.
Molecular Imaging and Biology|July 25, 2023
PI-RADS-Based Segmented Threshold of PSMA-PET SUVmax Is Better than Traditional Fixed Threshold for Diagnosing Clinically Significant Prostate Cancer Especially for PI-RADS 3 LesionsXiaoli Meng, Wenhui Ma, Jingliang Zhang, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2025
Performance of PRIMARY Score based on PSMA-PET imaging in suspected prostate cancer patients with different PSA ranges: a retrospective studyFuhao Zhang, Xiang Li, Jingliang Zhang, et al.
Advances in Therapy|December 4, 2023
Efficacy and Safety of Disitamab Vedotin Combined with Programmed Death-1 Inhibitor for Advanced Urothelial Cancer: A Case-Series StudyHongfan Zhao, Zhicheng Xu, Chengbin Li, et al.
Neuropsychiatric Disease and Treatment|February 5, 2021
Irreversible Primary Visual Cortex Impairment in a Mouse Model of High-Risk SchizophreniaXinying Chen, Ce Chen, Feng Ji, et al.
International Journal of Oncology|May 31, 2018
High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathwayJingliang Zhang, Shuai Shao, Donghui Han, et al.
The Prostate|February 23, 2026
A Dual-Threshold Strategy Enables Reliable Biopsy-Free Diagnosis of High-Risk Prostate CancerYong Liang, Zhiqiang Chen, Jingliang Zhang, et al.
Frontiers in Immunology|December 8, 2025
Correction: Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic targetFanchao Wei, Zhaoxiang Wang, Ruochen Qi, et al.
Frontiers in Immunology|November 7, 2025
Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic targetFanchao Wei, Zhaoxiang Wang, Ruochen Qi, et al.
Frontiers in Immunology|October 20, 2025
Visualizing early allograft rejection: an M1 macrophage-specific GLUT1 probe predicts TCMR onset in renal transplantationZhaoxiang Wang, Fanchao Wei, Dayuan Huang, et al.
Pageof 10